Join over 2,000+ Investors
Register now and embark on your journey to informed and successful investing.
ANI Pharmaceuticals Inc
ANIP | US
78.64
USD0.58
0.74%
ANIP | US
Loading StockChartView...
About ANI Pharmaceuticals Inc
Sector
Healthcare
Industry
Biotechnology
Earnings date
30/06/2024
As of date
24/04/2026
Close
78.64
Open
77.88
High
79.22
Low
76.84
ANI Pharmaceuticals Inc. a biopharmaceutical company develops manufactures and markets branded and generic prescription pharmaceuticals in the United States and Canada. It focuses on producing controlled substances oncology products hormones and steroids injectables and other formulations including extended release and combination products. The company manufactures oral solid dose products; semi-solids liquids and topicals; and potent products as well as performs contract development and manufacturing of pharmaceutical products. It markets its products through retail pharmacy chains wholesalers distributors and mail order pharmacies and group purchasing organizations. ANI Pharmaceuticals Inc. was incorporated in 2001 and is headquartered in Baudette Minnesota.
View LessANIP | US
Risk
34.1
Sharpe
0.27
Luna's Score
52/100
Recommendation
Hold
Luna says (ANIP | US)
What's Working
Low Market Beta (-0.4 to 0.8)
Value Stock (Price to Book < 3)
Strong Revenue Growth (> 10%)
What's not Working
Price Below SMA10D
Smallcap (300M - 2B USD)
Weak Operating Margin (< 10%)
Weak Sharpe Ratio (< 0.3)
Volatility Signals
Bullish: Stable Volatility (6-month <= 1-month volatility) is positive for the stock performance.
Risk Meter
Loading RiskMeterView...
10 days
32.1%1 month
34.1%3 months
32.4%6 months
33.5%Returns
Loading ReturnMeterView...
Fundamental Ratios
PE
50.68
Fwd. PE
9.89
Price to book
2.78
Debt to equity
0.68
Debt to assets
0.34
Ent. to EBITDA
11.41
Ent. to rev.
2.47
PEG
1.06
Other Fundamentals
EBITDA
107.97M
MarketCap
1.65B
MarketCap(USD)
1.65B
Div. yield
-
Op. margin
6.54
Erngs. growth
1.38K
Rev. growth
18.40
Ret. on equity
5.90
Short ratio
5.11
Short perc.
14.01
Market Sentiment (SMA and Price signals)
Short-term: Bullish (SMA10D > SMA1M)
Intermediate-term: Bullish (SMA1M > SMA3M)
Long-term: Bullish (SMA6M > SMA12M)
SMAs: Stock Price Trends
Loading MovingAverageView...
Range10D
6.55
Range1M
9.80
Range3M
15.42
Volumes: Market Activity
Volume Averages
Loading VolumeAverageView...
Rel. volume
0.61
Price X volume
14.94M
Peers
Diversifiers
Industry Comparison
| Parameter | Company | Industry | Indicator |
|---|---|---|---|
| Enterprise to EBITDA | 11.41 | 0.53 | Expensive |
| Ent. to Revenue | 2.47 | 3,967.00 | Cheaper |
| PE Ratio | 50.68 | 41.03 | Expensive |
| Price to Book | 2.78 | 15.55 | Cheaper |
| Dividend Yield | - | 2.20 | - |
| Std. Deviation (3M) | 32.40 | 72.80 | Lower Risk |
| Debt to Equity | 0.68 | -1.23 | Expensive |
| Debt to Assets | 0.34 | 0.25 | Expensive |
| Market Cap | 1.65B | 3.66B | Emerging |
